Search research articles
Contact Us
Filters
Showing results (121-130 of 151) with videos related to
Page
of 16
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 29, 1999
Increase in penicillin resistance rates in Belgium due to clonal spread of a penicillin-resistant 23F Streptococcus pneumoniae strain
A Hoefnagels-Schuermans, J Van Eldere, S Van Lierde, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1982
Comparative pharmacokinetics of ceftazidime and moxalactam
T B Tjandramaga, A Van Hecken, A Mullie, et al.
Critical Care Medicine
|
January 1, 1997
Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit
C Verwaest, J Verhaegen, P Ferdinande, et al.
Acta Clinica Belgica
|
January 1, 1982
Comparative study of in vitro antimicrobial activity and human pharmacokinetics of dibekacin and tobramycin
L Verbist, T B Tjandramaga, A Mullie, et al.
Journal of Clinical Microbiology
|
October 1, 1990
Characterization, in vitro susceptibility, and clinical significance of CDC group HB-5 from Rwanda
J Bogaerts, J Verhaegen, W Martinez Tello, et al.
Acta Paediatrica Belgica
|
October 1, 1980
Intraventricular and or intralumbar treatment of purulent meningitis in infants
R Eeckels, L Corbeel, C De Boeck, et al.
Lancet (London, England)
|
August 2, 1980
Intraventricular gentamicin in meningitis
L Corbeel, K de Boeck, N Logghe, et al.
Lancet (London, England)
|
March 24, 1979
Treatment of purulent meningitis in infants
L Corbeel, K de Boeck, N Logghe, et al.
Scandinavian Journal of Respiratory Diseases. Supplementum
|
January 1, 1978
Clinical significance of precipitating anti-rifampicin antibodies
E Stevens, J Bloemmen, E Saerens, et al.
British Journal of Clinical Pharmacology
|
August 1, 1984
The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure
G A Verpooten, L Verbist, A P Buntinx, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 151) with videos related to
Sort By:
Page
of 16
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 29, 1999
Increase in penicillin resistance rates in Belgium due to clonal spread of a penicillin-resistant 23F Streptococcus pneumoniae strain
A Hoefnagels-Schuermans, J Van Eldere, S Van Lierde, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1982
Comparative pharmacokinetics of ceftazidime and moxalactam
T B Tjandramaga, A Van Hecken, A Mullie, et al.
Critical Care Medicine
|
January 1, 1997
Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit
C Verwaest, J Verhaegen, P Ferdinande, et al.
Acta Clinica Belgica
|
January 1, 1982
Comparative study of in vitro antimicrobial activity and human pharmacokinetics of dibekacin and tobramycin
L Verbist, T B Tjandramaga, A Mullie, et al.
Journal of Clinical Microbiology
|
October 1, 1990
Characterization, in vitro susceptibility, and clinical significance of CDC group HB-5 from Rwanda
J Bogaerts, J Verhaegen, W Martinez Tello, et al.
Acta Paediatrica Belgica
|
October 1, 1980
Intraventricular and or intralumbar treatment of purulent meningitis in infants
R Eeckels, L Corbeel, C De Boeck, et al.
Lancet (London, England)
|
August 2, 1980
Intraventricular gentamicin in meningitis
L Corbeel, K de Boeck, N Logghe, et al.
Lancet (London, England)
|
March 24, 1979
Treatment of purulent meningitis in infants
L Corbeel, K de Boeck, N Logghe, et al.
Scandinavian Journal of Respiratory Diseases. Supplementum
|
January 1, 1978
Clinical significance of precipitating anti-rifampicin antibodies
E Stevens, J Bloemmen, E Saerens, et al.
British Journal of Clinical Pharmacology
|
August 1, 1984
The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure
G A Verpooten, L Verbist, A P Buntinx, et al.
Page
of 16